Portfolio (Quarterly)
Guide ↗
Virtus Investment Advisers, LLC
· CIK 0000019481| # | Ticker | Company | Sector | Shares | Value ↓ | % Port | Chg Shares | Chg % | Period Price ① | Since Period ① |
|---|---|---|---|---|---|---|---|---|---|---|
| 341 | ALLO | ALLOGENE THERAPEUTICS INC | Healthcare | 172,209.0 | $358K | 0.08% | -8K | -4.6% | $2.08 | -17.3% |
| 342 | RAPP | RAPPORT THERAPEUTICS INC | Healthcare | 8,521.0 | $355K | 0.08% | -486.0 | -5.4% | $41.67 | +2.4% |
| 343 | BLW | BLACKROCK LTD DURATION INCOM | Financial Services | 28,365.0 | $354K | 0.08% | -3K | -8.3% | $12.49 | -2.9% |
| 344 | NGNE | NEUROGENE INC | Healthcare | 11,244.0 | $354K | 0.08% | -2K | -13.7% | $31.45 | +7.1% |
| 345 | IMTX | IMMATICS N.V | Healthcare | 34,882.0 | $353K | 0.08% | +8K | +28.4% | $10.13 | -15.1% |
| 346 | CMPX | COMPASS THERAPEUTICS INC | Healthcare | 161,181.0 | $353K | 0.08% | +108K | +205.0% | $2.19 | -15.5% |
| 347 | — | DISC MEDICINE INC | — | 4,812.0 | $352K | 0.08% | +2K | +62.2% | $73.14 | — |
| 348 | LXEO | LEXEO THERAPEUTICS INC | Healthcare | 74,874.0 | $349K | 0.08% | +47K | +168.3% | $4.66 | -11.3% |
| 349 | — | BLACKROCK INCOME TR INC | — | 32,326.0 | $347K | 0.08% | -6K | -15.4% | $10.72 | — |
| 350 | GAIN | GLADSTONE INVT CORP | Financial Services | 22,223.0 | $344K | 0.08% | -19K | -45.8% | $15.46 | +3.1% |
| 351 | BCYC | BICYCLE THERAPEUTICS PLC | Healthcare | 80,789.0 | $343K | 0.08% | +44K | +120.7% | $4.24 | -13.4% |
| 352 | ARDC | ARES DYNAMIC CR ALLOCATION F | Financial Services | 27,117.0 | $342K | 0.08% | -7K | -21.0% | $12.63 | -4.7% |
| 353 | MLTX | MOONLAKE IMMUNOTHERAPEUTICS | Healthcare | 17,507.0 | $341K | 0.08% | -929.0 | -5.0% | $19.47 | -37.3% |
| 354 | RLMD | RELMADA THERAPEUTICS INC | Healthcare | 49,202.0 | $340K | 0.08% | NEW | — | $6.92 | -35.8% |
| 355 | SMMT | SUMMIT THERAPEUTICS INC | Healthcare | 23,355.0 | $340K | 0.08% | +8K | +50.5% | $14.57 | +19.4% |
| 356 | CABA | CABALETTA BIO INC | Healthcare | 108,703.0 | $338K | 0.08% | NEW | — | $3.11 | -16.6% |
| 357 | — | INHIBRX BIOSCIENCES INC | — | 3,549.0 | $336K | 0.08% | +124.0 | +3.6% | $94.75 | — |
| 358 | ARCC | ARES CAPITAL CORP | Financial Services | 18,080.0 | $335K | 0.08% | -6K | -24.3% | $18.53 | +4.5% |
| 359 | TNGX | TANGO THERAPEUTICS INC | Healthcare | 10,576.0 | $331K | 0.08% | -19K | -63.7% | $31.26 | -23.6% |
| 360 | — | CRESCENT BIOPHARMA INC. | — | 18,258.0 | $329K | 0.08% | NEW | — | $18.00 | — |
① Period Price is the implied market price on the last day of the reporting period, calculated as reported value ÷ shares held. It is not the fund's purchase price or cost basis — the fund may have initiated or added to the position at any point during the quarter at a different price. Since Period shows the price change from that quarter-end snapshot to today's last price — it reflects stock movement after the report date, not the fund's actual return.
Sector Allocation
Healthcare
36.7%
Technology
15.7%
Financial Services
15.2%
Industrials
13.0%
Consumer Cyclical
5.8%
Energy
4.7%
Real Estate
2.8%
Utilities
1.7%
Communication Services
1.7%
Basic Materials
1.5%